Edition:
India

Global Blood Therapeutics Inc (GBT.OQ)

GBT.OQ on NASDAQ Stock Exchange Global Select Market

56.30USD
18 Jun 2019
Change (% chg)

-- (--)
Prev Close
$56.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
233,962
52-wk High
$62.93
52-wk Low
$30.16

About

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,412.94
Shares Outstanding(Mil.): 43.68
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates